CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $174,000 | -23.7% | 54,600 | +0.2% | 0.00% | – |
| Q4 2021 | $228,000 | -48.5% | 54,500 | 0.0% | 0.00% | – |
| Q3 2021 | $443,000 | +7.8% | 54,500 | 0.0% | 0.00% | – |
| Q2 2021 | $411,000 | -9.5% | 54,500 | +4.2% | 0.00% | – |
| Q1 2021 | $454,000 | +8.9% | 52,300 | 0.0% | 0.00% | – |
| Q4 2020 | $417,000 | 0.0% | 52,300 | 0.0% | 0.00% | – |
| Q3 2020 | $417,000 | -19.5% | 52,300 | 0.0% | 0.00% | – |
| Q2 2020 | $518,000 | +51.5% | 52,300 | +18.3% | 0.00% | – |
| Q1 2020 | $342,000 | +302.4% | 44,200 | +100.9% | 0.00% | – |
| Q4 2019 | $85,000 | -23.4% | 22,000 | 0.0% | 0.00% | – |
| Q3 2019 | $111,000 | -23.4% | 22,000 | 0.0% | 0.00% | – |
| Q2 2019 | $145,000 | -3.3% | 22,000 | +11.1% | 0.00% | – |
| Q1 2019 | $150,000 | +66.7% | 19,800 | +78.4% | 0.00% | – |
| Q4 2018 | $90,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |